| POLAR CAPITAL BIOTECHNOLOGY I USD DIS | BIOTECNOLOGÍA | 19,88% | 43,18% | 82,86% | 218,73% |
| BNP PARIBAS RESPONSIBLE US VALUE MULTI-FACTOR EQUITY CLASSIC H EUR CAP | RVI USA VALOR | 10,30% | 41,65% | 82,84% | · |
| CARMIGNAC INVESTISSEMENT A CHF ACC HDG | RVI GLOBAL | 26,75% | 76,25% | 82,84% | 142,67% |
| FIDELITY FUNDS-INDIA FOCUS Y-ACC-EUR | RVI ASIA EX-JAPÓN | -4,18% | 16,34% | 82,83% | 135,22% |
| FIDELITY FUNDS-NORDIC A-DIST-SEK | RVI EUROPA | 16,53% | 34,74% | 82,83% | 123,52% |
| UBS GLOBAL GENDER EQUALITY UCITS ETF HGBP ACC | RVI GLOBAL | 5,99% | 28,96% | 82,83% | · |
| WAVERTON GLOBAL EQUITY FUND A USD DIS | RVI GLOBAL | 9,64% | 53,52% | 82,83% | 139,35% |
| MULTICOOPERATION SICAV - JULIUS BAER GLOBAL EXCELLENCE EQUITY K GBP | RVI GLOBAL VALOR | 6,69% | 61,39% | 82,80% | · |
| GOLDMAN SACHS GLOBAL SMALL CAP CORE EQUITY PORTFOLIO E (SNAP) EUR CAP | RVI GLOBAL SMALL/MID CAP | 11,93% | 37,27% | 82,79% | 121,07% |
| GOLDMAN SACHS EUROPE EQUITY INCOME R CAP EUR | RVI EUROPA VALOR | 15,51% | 41,39% | 82,76% | · |
